7 May '19
Biologists in Novosibirsk, in Siberia, have developed special nanoparticles that are said to be able to lower blood pressure, and are reported to have successfully tested the drug candidate on hypertension afflicted rats.
In a recent update Asya Levina, a researcher at the Novosibirsk State University (NSU), was quoted as saying that their solution is a system that consists of nanoparticles and short DNA molecules. “The former help the latter enter cells and bond with messenger ribonucleic acid (mRNA), thus preventing protein from forming. That results in no increase in the number of receptors on the cells, and the patient does not develop arterial hypertension.”
Reports by the World Health Organization (WHO) list cardiovascular diseases, including infarcts, strokes and chronic heart failures, as the number one natural killer globally. The diseases claim about 17 million people each year, and most of the victims hit their death road by developing chronic high blood pressure.